Kewaunee Scientific’s Share Price Out of Step with Positive Results

December 22, 2023

☀️Trending News

Kewaunee Scientific ($NASDAQ:KEQU) is a leader in the design and manufacture of laboratory, healthcare, and technical furniture. Despite reporting strong quarterly results and giving an upbeat outlook for the year ahead, the share price of Kewaunee Scientific has not kept pace with its performance. This is puzzling given that the company has reported growth in net income and revenue for the last five quarters, showing that it is well-positioned to capitalize on the robust demand for its products. Kewaunee Scientific’s commitment to customer service, product innovation, and quality control has made them a leader in the laboratory and healthcare furniture industry. The company has shown strong revenue growth in the last five quarters, and its recent quarterly results have been largely positive.

Despite this, its share price does not appear to have kept up with its performance. This could mean that investors are expecting slower growth in the near future, or perhaps they are taking a more cautious approach to investing in the company. Whatever the case, it is clear that Kewaunee Scientific is doing well and should continue to perform well in the coming quarters.

Stock Price

Kewaunee Scientific‘s share price has been surprisingly out of step with the company’s positive results. On Tuesday, KEWAUNEE SCIENTIFIC stock opened at $24.5 and closed at $26.0, resulting in a 7.5% rise from its prior closing price of 24.2. This is despite the fact that the company has seen a number of positive developments in recent months, including growing sales, improved profitability, and new product launches. While the stock may have been undervalued in the past, it appears as though the market is beginning to recognize the company’s potential and reward it accordingly. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Kewaunee Scientific. More…

    Total Revenues Net Income Net Margin
    215.08 6.93 3.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Kewaunee Scientific. More…

    Operations Investing Financing
    0.7 -4.15 14.93
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Kewaunee Scientific. More…

    Total Assets Total Liabilities Book Value Per Share
    121.71 78.29 14.5
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Kewaunee Scientific are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    14.3% -28.2% 6.7%
    FCF Margin ROE ROA
    -2.2% 22.1% 7.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    The result from our Star Chart showed that the company is very strong in growth, and medium in asset, profitability and dividend. Our health score for KEWAUNEE SCIENTIFIC was 6/10, suggesting that its cashflows and debt are at an intermediate level, which may be enough to pay off debt and fund future operations. Additionally, we classified KEWAUNEE SCIENTIFIC as a ‘cheetah’, indicating that it has achieved high revenue or earnings growth, but is considered less stable due to lower profitability. Given the combination of its high growth and low stability, this type of company may appeal to investors who are looking for higher returns with higher risk. Investors willing to take on higher risk may be attracted to KEWAUNEE SCIENTIFIC’s potential to deliver higher returns in the long run. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Kewaunee Scientific Corp, Siam Steel International PCL, Varangis Avepe SA, and PT Gema Graha Sarana Tbk are leading international corporations in the laboratory furniture and equipment industry. They are highly competitive in this sector, providing top-notch products and services that cater to the needs of their customers. Each company has its own unique strengths and rigorous processes that make them stand out from the rest.

    – Siam Steel International PCL ($SET:SIAM-R)

    Siam Steel International PCL is a leading steel manufacturer in Thailand. It produces a wide range of steel products, including automotive parts, construction materials, and agricultural machinery. As of 2023, the company has a market capitalization of 830.38M, indicating investor confidence in the company’s long-term prospects. The company has a negative Return on Equity (ROE) of -0.78%, which is an indicator that it is not generating enough returns from its investments. Despite this, Siam Steel International PCL has continued to be successful in providing quality steel products to its customers.

    – Varangis Avepe SA ($LTS:0QC6)

    Gema Graha Sarana Tbk is a publicly traded Indonesian company that specializes in investment holding and property management. The company’s market cap of 406.4B as of 2023 is a reflection of its robust financial position and profitability. Furthermore, the company’s Return on Equity (ROE) stands at 13.37%, highlighting its strong ability to generate profits from its shareholders’ investment. All of these factors illustrate the strength of Gema Graha Sarana Tbk as one of the largest and most successful companies in Indonesia.

    Summary

    Investing analysis of Kewaunee Scientific has recently shown a positive movement in the company’s stock price. This comes despite the fact that the company’s results have yet to catch up to its share price. Analysts attribute the positive movement to Kewaunee Scientific’s strong fundamentals, which are expected to translate into future performance. The company has a strong portfolio of products and services, a strong balance sheet, and has been profitable for several years.

    Additionally, Kewaunee Scientific has a good management team and a well-defined strategy. This combined with the recent positive stock price movement is what has made Kewaunee Scientific an attractive investment option for many investors.

    Recent Posts

    Leave a Comment